Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease - PubMed (original) (raw)

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease

T Lehtimäki et al. Hum Genet. 1995 Jan.

Abstract

The apoE phenotype of 83 patients with probable Alzheimer's disease (AD) and of 164 non-demented controls was determined by isoelectric focusing and Western blotting. The proportion of the epsilon 4 allele was 0.548 in AD and 0.202 in controls (P < 0.0001). The effect was seen in both early-onset and late-onset AD patients. The risk of AD in epsilon 4 homozygotes was 18-fold greater than in individuals without the epsilon 4 allele. ApoE concentrations were measured in serum and cerebrospinal fluid (CSF) from a subgroup of patients with AD (n = 72) and controls (n = 84) by a sandwich enzyme-linked immunosorbent assay. Although serum apoE concentrations were lower in individuals with the epsilon 4 allele than in those without the epsilon 4 allele, CSF apoE concentrations did not vary in different phenotype groups. However, CSF apoE levels were lower in AD patients than in controls. We conclude that the inheritance of the epsilon 4 allele of apoE is a risk factor for AD in the Finnish population.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nature. 1991 Oct 31;353(6347):844-6 - PubMed
    1. Am J Hum Genet. 1988 Jan;42(1):104-12 - PubMed
    1. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8098-102 - PubMed
    1. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977-81 - PubMed
    1. J Med Genet. 1994 Mar;31(3):197-200 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources